2022 SVB Report Results

We are proud to announce that ShangBay Capital is once again ranked #1 again as the Most Active New Device Investor both in the U.S. and Europe from the most recently released Silicon Valley Bank Annual Healthcare Report! In addition, ShangBay is also ranked #2 under the Imaging investment category.